Novavax Inc (NVAX)
3.895
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
3.91
+0.02
(+0.39%)
After-Hours: 20:00
Novavax Revenue (TTM): 693.46M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 693.46M |
| September 30, 2023 | 727.89M |
| June 30, 2023 | 1.334B |
| March 31, 2023 | 1.096B |
| December 31, 2022 | 1.707B |
| September 30, 2022 | 692.39M |
| June 30, 2022 | 242.93M |
| March 31, 2022 | 355.02M |
| December 31, 2021 | 197.58M |
| September 30, 2021 | 750.54M |
| June 30, 2021 | 728.72M |
| March 31, 2021 | 466.24M |
| December 31, 2020 | 22.39M |
| September 30, 2020 | 204.76M |
| June 30, 2020 | 50.24M |
| March 31, 2020 | 18.06M |
| December 31, 2019 | 18.66M |
| September 30, 2019 | 15.97M |
| June 30, 2019 | 21.20M |
| March 31, 2019 | 28.62M |
| December 31, 2018 | 34.29M |
| September 30, 2018 | 38.57M |
| June 30, 2018 | 39.19M |
| March 31, 2018 | 35.15M |
| December 31, 2017 | 31.18M |
| Date | Value |
|---|---|
| September 30, 2017 | 26.16M |
| June 30, 2017 | 21.04M |
| March 31, 2017 | 16.82M |
| December 31, 2016 | 15.35M |
| September 30, 2016 | 15.81M |
| June 30, 2016 | 19.10M |
| March 31, 2016 | 30.59M |
| December 31, 2015 | 36.25M |
| September 30, 2015 | 37.12M |
| June 30, 2015 | 38.81M |
| March 31, 2015 | 33.07M |
| December 31, 2014 | 30.66M |
| September 30, 2014 | 32.68M |
| June 30, 2014 | 29.27M |
| March 31, 2014 | 24.54M |
| December 31, 2013 | 20.91M |
| September 30, 2013 | 16.73M |
| June 30, 2013 | 17.70M |
| March 31, 2013 | 21.27M |
| December 31, 2012 | 22.08M |
| September 30, 2012 | 23.36M |
| June 30, 2012 | 22.60M |
| March 31, 2012 | 18.50M |
| December 31, 2011 | 14.69M |
| September 30, 2011 | 8.894M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
15.97M
Minimum
Sep 2019
1.707B
Maximum
Dec 2022
491.71M
Average
355.02M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Pfizer Inc | 58.50B |
| Moderna Inc | 6.754B |
| Agilent Technologies Inc | 6.735B |
| Align Technology Inc | 3.862B |
| Lexicon Pharmaceuticals Inc | 1.205M |